TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.

Chloe Orkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.